A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine
Clinical trial NCT04683224 · WITHDRAWN
Trial details
- NCT number
- NCT04683224
- Sponsor
- Vaxxinity, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2023-03-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.